Using a Structured Medical Note for Determining the Safety Profile of Anthrax Vaccine for US Soldiers in Korea

摘要

Selected military personnel are immunized with an FDA-licensed anthrax vaccine unless there are clinical contraindications. The objective of this analysis is to capture the experience of soldiers receiving anthrax vaccine to assist in better patient-provider communications and clarify the safety profile of the vaccine in this population as a quality-assurance initiative. Between August 1998 and July 1999, 2824 soldiers immunized against anthrax at one military clinic completed a structured medical note that was reviewed by a clinician. Female gender, prior vaccine-associated adverse events, and medications use were significantly related to higher reports of adverse events. All reported immediate consequences resolved.